Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126466611 | 12646661 | 1 | I | 20160720 | 20160729 | 20160812 | 20160812 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121512 | RANBAXY | 0.00 | Y | 0.00000 | 20160812 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126466611 | 12646661 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | N | U | 91038 | 5 | MG | |||||||
| 126466611 | 12646661 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | U | 0 | |||||||||
| 126466611 | 12646661 | 3 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | U | U | 0 | |||||||||
| 126466611 | 12646661 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | U | U | 0 | |||||||||
| 126466611 | 12646661 | 5 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | U | U | 0 | |||||||||
| 126466611 | 12646661 | 6 | C | ZOPICLONE | ZOPICLONE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126466611 | 12646661 | 1 | Mental disorder |
| 126466611 | 12646661 | 2 | Product used for unknown indication |
| 126466611 | 12646661 | 3 | Product used for unknown indication |
| 126466611 | 12646661 | 4 | Product used for unknown indication |
| 126466611 | 12646661 | 5 | Product used for unknown indication |
| 126466611 | 12646661 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126466611 | 12646661 | HO |
| 126466611 | 12646661 | DS |
| 126466611 | 12646661 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126466611 | 12646661 | Blood triglycerides increased | |
| 126466611 | 12646661 | Diarrhoea | |
| 126466611 | 12646661 | Electrocardiogram QT prolonged | |
| 126466611 | 12646661 | Hyperosmolar hyperglycaemic state | |
| 126466611 | 12646661 | Hypotension | |
| 126466611 | 12646661 | Malaise | |
| 126466611 | 12646661 | Neuroleptic malignant syndrome | |
| 126466611 | 12646661 | Polydipsia | |
| 126466611 | 12646661 | Polyuria | |
| 126466611 | 12646661 | Renal failure | |
| 126466611 | 12646661 | Tachypnoea | |
| 126466611 | 12646661 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126466611 | 12646661 | 1 | 20160712 | 20160719 | 0 |